HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2005-0484v1 24/4/908    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagasawa, Y. Articles by Blau, C. A. Search for Related Content PubMed PubMed Citation Articles by Nagasawa, Y. Articles by Blau, C. A.

TECHNOLOGY DEVELOPMENT

Anatomical Compartments Modify the Response of Human Hematopoietic Cells to a Mitogenic Signal

^a Department of Medicine,
^b Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA;
^c Division of Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Key Words. Gene therapy • In vivo selection • Regulation • Hematopoiesis

Correspondence: C. Anthony Blau, M.D., K260 Health Sciences Building, Mailstop 357710, University of Washington, Seattle, Washington 98195, USA. Telephone: 206-685-6873; Fax: 206-543-3560; e-mail: tblau{at}u.washington.edu

Received September 30, 2005; accepted for publication December 14, 2005.
Methods for specifically regulating transplanted cells have many applications in gene and cell therapy. We examined the response of human cord blood CD34⁺ cells to a specific mitotic signal in vivo. Using a conditional signaling molecule (F36VMpl) that is specifically activated by an artificial ligand called a chemical inducer of dimerization (CID), human hematopoietic cells transplanted into immune deficient mice were induced to proliferate. Only differentiating erythroid precursors and multipotential and erythroid progenitors (colony-forming unit [CFU]-mix and burst forming unitserythroid [BFUe]) responded; however, the nature of the response differed markedly between bone marrow and spleen. In the marrow, F36VMpl induced a 12- to 17-fold expansion of differentiated erythroid precursors and a loss of CFU-mix and BFUe. In the spleen, F36VMpl induced a marked rise in BFUe and CFU-mix and, relative to marrow, a much less prominent rise in more mature red cells. Clonal analysis was most consistent with the interpretation that the spleen and bone marrow differentially regulate the response of human progenitors to a mitotic signal, possibly influencing progenitor expansion versus differentiation. These findings establish CIDs as in vivo growth factors for human hematopoietic cells.

This article has been cited by other articles:

				H. Abdel-Azim, Y. Zhu, R. Hollis, X. Wang, S. Ge, Q.-L. Hao, G. Smbatyan, D. B. Kohn, M. Rosol, and G. M. Crooks Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl Blood, April 15, 2008; 111(8): 4064 - 4074. [Abstract] [Full Text] [PDF]